Frede Donskov

12PUBLICATIONS

42CO-AUTHORS

Cancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 02, 2026

Navigating the cancer trajectory in colorectal cancer: perceptions of cure over care, efficiency, and limited emotional support.

|Jun 03, 2025

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol.

Jakob N Henriksen, Charlotte U Andersen, Frede Donskov

|Mar 28, 2024

Cytoreductive Nephrectomy in Select Primary Metastatic Renal Cell Carcinoma Patients: A Comprehensive Nationwide Outcome Analysis.

Nessn Azawi, Louise Geertsen, Naomi Nadler

|Sep 28, 2023

Lifestyle and Clinical Factors in a Nationwide Stage III and IV Renal Cell Carcinoma Study.

Nessn Azawi, Freja Ejlebaek Ebbestad, Naomi Nadler

|Aug 07, 2023

Late adverse events to iodinated contrast media in patients treated with IL-2: a safety report from the Danish Renal Carcinoma Group (DaRenCa) study - 1.

Aska Drljevic-Nielsen, Nikolaj Skou, Jill R Mains

|Sep 16, 2022

Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma.

Frede Donskov, Cathy Anne Pinto, Raluca Predoiu

Pageof 2

Frequent Collaborators

3 joint publications

Susanne Oksbjerg Dalton

Nessn Azawi

Niels Fristrup

Charles Schloss

Rustem Airatovich Gafanov

Georg A Bjarnason

Jae-Lyun Lee

David F McDermott

Ole Andersen

Sabina Signoretti

Frequent Collaborators

3 joint publications

Susanne Oksbjerg Dalton

3 joint publications

Nessn Azawi

3 joint publications

Niels Fristrup

2 joint publications

Charles Schloss